<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00286351</url>
  </required_header>
  <id_info>
    <org_study_id>endo 220604</org_study_id>
    <nct_id>NCT00286351</nct_id>
  </id_info>
  <brief_title>Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      Does a combination of Arimidex and Zoladex make endometriomas shrink and how is the following
      IVF outcome
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>size of endometriomas after 2Â½ month of combined downregulation</measure>
  </primary_outcome>
  <enrollment>20</enrollment>
  <condition>Endometriosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combined treatment with Arimidex and Zoladex before IVF</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endometrioma(s)with a size of 20-70 mm, persisted for at least 3 cycles

          -  Couples with indication and wish for IVF/ICSI

          -  Age of women: 20-40 years

          -  Regular menstrual cycle within normal range (21-35 days)

          -  Body Mass Index (BMI): 18-30 kg/m2

        Exclusion Criteria:

          -  History with osteoporosis, liver-, kidney- or heart disease or thromboembolic disease

          -  Treatment of endometriosis with GnRH agonist during the last 3 month
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristine Lossl, medical doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Fertility Clinic, Copenhagen University Hospital Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen East</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2006</study_first_submitted>
  <study_first_submitted_qc>February 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2006</study_first_posted>
  <last_update_submitted>April 20, 2007</last_update_submitted>
  <last_update_submitted_qc>April 20, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 23, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anastrozole</mesh_term>
    <mesh_term>Goserelin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

